Lyophilization Services of New England (LSNE), a contract development and manufacturing organization (CDMO), has acquired cGMP aseptic fill finish manufacturing facility from PSC Biotech for an undisclosed sum.
Located in Madison of Wisconsin, the acquired facility will help LSNE to expand its manufacturing capabilities, in addition to meeting its customers’ project timing requirements.
The acquired facility will be named as LSNE-Madison, which will complement LSNE’s existing full-service parenteral manufacturing capabilities, including vial filling, lyophilization, process development, QC analytical, secondary packaging and stability studies.
LSNE-Madison is a 37,000ft² multi-product facility that will be used for the manufacturing of final drug products for pre-clinical to phase III/commercial use.
The facility will also provide regulatory support for clinical and commercial products, along with the firm’s three other FDA-inspected manufacturing sites.
The fill finish facility will also enhance LSNE’s capabilities with the addition of terminal sterilization of final product and additional quality control services.
LSNE CEO Matthew Halvorsen said: “We have experienced strong growth and increased demand over the last few years, and as the market continues to expand, we know it is imperative to be able to offer increased scheduling flexibility to existing and new clients.
“With the support of the Permira Funds, we are increasing our capacity to provide our clients with additional manufacturing redundancy backed by the outstanding level of service that LSNE is known for.”
LSNE COO Shawn Cain said: “We look forward to working with the staff to build LSNE-Madison into a world class aseptic fill/finish facility focused on the manufacturing of lyophilized and liquid drug products.”
Since 1997, LSNE has been offering contract lyophilization services to the pharmaceutical, biotechnology and medical device industries
The firm is specialized in a range of services such as cycle development, cGMP fill finish, and lyophilization. Its three other facilities are located in New England.